
Backed by
Raised $75M in Series A on February 20, 2025 led by Sequoia.
OpenEvidence is a next-generation AI platform transforming how healthcare professionals and organizations access and apply medical information. Built on cutting-edge large language models and deep clinical data, OpenEvidence enables faster, more reliable, and more personalized decision-making for clinicians and life sciences partners.